ICIUM 2011
Conference Videos

The following are videos of different sessions and speakers from the ICIUM 2011 Conference that took place in the Jasper Auditorium. 

 

Satellite: Pharmaceutical System Strengthening: Is There a Need for a New Paradigm?
Monday, November 14, 2011
Presentations:
  • Akatari Mamtaz (MOHFW, Bangladesh)
  • David Ofori-Adjei (Ghana College of Physicians and Surgeons, Ghana)
  • Andreas Seiter (World Bank, USA)
  • Richard Ogilvie Laing (WHO, Switzerland)
  • Douglas L. Keene (MSH/SPS Program, USA)
Satellite Video

 


Welcome Address
Monday November 14, 2011
Presentations:

  • John Chalker (MSH/USA)
  • Recep Akdağ (Minister of Health, Turkey
  • Rıza Murat Karaşen (General Manager of General Health Insurance, Turkey)
  • Zsuzsanna Jakab (Regional Director, EURO, Denmark)
  • Hussein Abdel-Razzak Al Gezairy (EMRO, Egypt), Mohamed Bin Shahna
  • H.E. Dr Ahmed bin Mohamed bin Obaid Al Saidi (Minister of Health, Sultanate of Oman, Oman)
  • Anita Katharina Wagner (Harvard Medical School, USA)

Welcome Address Video

 

 

Opening: Keynote Addresses
Monday, November 14, 2011
Presentations:

  • From ICIUM 2004 to ICIUM 2011 - Challenges and Opportunities for Medicines Access and Use
    • Suwit Wibulpolprasert (Ministry of Public Health, Thailand)
  • Public Policies to Improve Drug Access for Chronic Diseases: The Experience of Mexico
    • Ricardo Perez-Cuevas (Ministry of Health, Mexico)
  • Healthcare Reforms and Pharmaceuticals: Lessons from Turkey
    • Mehtap Tatar (Hacettepe University, Turkey)

Keynote Address Video

 

 

Effects of Turkish Health Reform on Pharmaceutical Policies
Monday, November 14, 2011
Presentations:

  • Hüseyin Kiliçaslan (Social Security Institution, Turkey)
  • Hanefi Ozbek (saglik Bakanligi, Turkey)

Turkish Health Reform Video

 

 

Rational Medicines Use Issues in Turkey - Yesterday, Today and Tomorrow
Monday, November 14, 2011
Presentations:

  • Ersin Yariş (Turkish Pharmacology Society, Turkey)
  • Harun Kızılay (Turkish Pharmacists` Association)
  • Burcak Deniz Dedeoglu (Ministry of Health of TURKEY, Turkey)

Rational Medicines Use Issues Video

 

 

Plenary 1: International and Regional Systems, Policies and Programs
Tuesday, November 15, 2011
Presentations:

  • Improving Use of Medicines - Where Are We Today?
    • Kathleen Anne Holloway (World Health Organization, India)
  • Corporate Responsibility of Pharmaceutical Companies Under Conditions of Market Failure and Failing States
    • Klaus Leisinger (Novartis Foundation for Sustainable Development, Switzerland)

Plenary 1 Video

 

 

Session 1b: Policy: The Pharmaceutical Policy Process
Tuesday, November 15, 2011
Presentations:

  • Improving Access and Quality Use of Medicines in Palliative Care within National Drug Policy, Regulatory, and Funding Frameworks
    • Debra Rowett (Drug and Therapeutics Information Service, Australia), Tania Shelby-James (Discipline, Palliative and Supportive Services, Finders University, Australia), Simon Eckerman (Mater Health Services and Center for Palliative Care Research and Education, Australia), Lynn Weekes (NPS: Better Choices - Better Health, Australia), David Currow (Discipline, Palliative and Supportive Services, Finders University, Australia)
  • Use of an Indicator-Based System for Assessing, Monitoring, and Improving Pharmacy Practice
    • Jennie Lates (MoHSS, Nigeria), Victor Sumbi (MSH/SPS), Dawn Pereko (MSH/SPS)
  • The Volume Share of Generic Medicines in the Retail Market Between 1999 and 2009: a Comparison between Brazil and Mexico
    • Rene Soria-Saucedo (Center for Health Systems Research, National Institute of Public Health, Mexico), Veronika Wirtz (Center for Global Health and Development, Boston University, USA), Warren Kaplan (Center for Global Health and Development, Boston University, USA)
  • Health Litigation and New Challenges in the Management of Pharmaceutical Services
    • Vera Lucia Edais Pepe (ENSP-Fiocruz, Brazil), Tatiana de Aragao Figueiredo (ENSP-Fiocruz, Brazil), Luciana Simas (ENSP-Fiocruz, Brazil), Claudia Garcia Serpa Osorio-de-Castro (ENSP-Fiocruz, Brazil), Miriam Ventura (IESC - Universidade FEderal do Rio de Janeiro, Brazil)

Session 1b Video

 

 

Plenary 2: National Systems, Policies, and Programs
Tuesday, November 15, 2011
Presentations:

  • National Approach to the Rational Use of Medicines: The Omani Experience
    • Bastool Jaffer Suleiman (MoH, Oman)
  • Experiences in Implementing a National Medicines Policy Change in China
    • Jing Sun (China National Health Development Research Center, MoH China, China)

Plenary 2 Video

 

 

Session 2b: Policy: Quality and Safety of Medicines in LMIC
Tuesday, November 15, 2011
Presentations:

  • Proposed Set of Indicators for Monitoring and Evaluation on Pharmacovigilance Activities
    • Amborse Ohumbagho Isah (University of Benin, Nigeria), Shanthi Pal (WHO, Switzerland), Sten Olsson (International Collaborating Center, Sweden)
  • Quality of Medicines in South Africa: Perceptions vs. Reality
    • Aarti Patel (Health Research for Action, Belgium; University of Otago, New Zealand), Robin Gauld (University of Otago, New Zealand), Pauline Norris (University of Otago, New Zealand), Thomas Rades ( University of Otago, New Zealand)
  • Study on Quality Assurance for Essential Medicines other than ARVs, Antimalarial and Antituberculosis Medicines
    • Joelle Daviaud (The Global Fund to Fight HIV, Tuberculosis and Malaria, Switzerland), Jean-Michel Caudron (The Global Fund to Fight HIV, Tuberculosis and Malaria, Switzerland), Corinne Pouget (Quamed, Institute of Tropical Medicine, Belgium), Monika Zweygarth (Quamed, Institute of Tropical Medicine, Belgium), Abu Saleh (The Global Fund to Fight HIV, Tuberculosis and Malaria, Switzerland), Carmen Perez Casas (The Global Fund to Fight HIV, Tuberculosis and Malaria, Switzerland), Sophie Logez (The Global Fund to Fight HIV, Tuberculosis and Malaria, Switzerland)
  • Inverventions to Improve Medication Safety in a University Hospital in Thailand
    • Wimon Anansakunwatt (Mahidol University, Thailand), Uraiwan Silpasupagornwong, Umporn Yoobang, Nareumon Dhana, Monwarat Laohajeerapan

Session 2b Video

 

 

Daily Summary for Tuesday, November 15, 2011
Wednesday, November 16, 2011
Presentation:

  • Tienie Stander (heXor, South Africa)

Tuesday Summary Video

 

 

Plenary 3: Health Care and Financing Institutions
Wednesday, November 16, 2011
Presentations:

  • Win-Win or Lose-Lose?  Why is Multi-Stakeholder Involvement Essential?
    • Saul Sebastian Walker (Department for International Development, UK)
  • University Health Coverage and Access to Medicines: Golden Ring or Trojan Horse?
    • Jonathan Dickinson Quick (Management Sciences for Health, USA)
  • A System Framework for Access to Medicines - Implications for Research and Policy
    • Maryam Bigdeli (WHO, Switzerland)

Plenary 3 Video

 

 

Session 3b: Policy: Policy Interventions to Improve Rational Use of Medicines in LMIC
Wednesday, November 16, 2011
Presentations:

  • New Performance-Based Reward Strategy to Improve Pharmacy Practices, Financial Management, and Appropriate medicines Use in the Public Sector in Uganda
    • Birna Trap (MSH, Uganda), Richard Semakula (MSH, Uganda), Martin Oteba (MoH, Pharmacy Division, Uganda), Kate Kikule (National Drug Authorities, Uganda), Belinda Blick (MSH, Uganda)
  • The Irrational Use of Drugs in Rural China: Evidences from Two Provinces
    • Qiang Sun (Center for Health Management and Policy, Shandong University, China), Jia Yin, Genyong Zuo, Qingyue Meng
  • Financial Impact of Judicious Use of Medicine in Primary Care
    • Yegin Zuo (NPS: Better Choices, Better Health, Australia), Stephen Morrell, Jonathan Dartnell, Lynn Weekes
  • Effects of Listing and Delisting in National Essential Medicine List on Utilization Patterns
    • Sauwakon Ratanawijitrasin (Mahidol University, Thailand), Sanita Hirunrassamee (Pharmacy Division, Phramongkutklao Hospital, Thailand)

Session 3b Video

 

 

Plenary 4: Health Care Providers
Wednesday, November 16, 2011
Presentations:

  • Improving Mental Health in Low-and Middle-Income Countries
    • Robert Sebbag (Sanofi-aventis Groupe, France)
  • Promoting Adherence to Antiretroviral Therapy Through System Interventions - the INRUD-IAA Experience
    • John Chalker (MSH, UK)
  • Chronic Diseases in Low and Middle Income Countries: A Framework for Long-Term Pharmacotherapeutic Care
    • Veronika Wirtz (National Institute of Public Health, Mexico)

Plenary 4 Video

 

 

Session 4b: Policy: Providers and Promotion
Wednesday, November 16, 2011
Presentations:

  • Marketing and Promotion of the Pharmaceutical Industry: Snapshot of Current Practice Within, or With Possible Implications In, Low- and Medium-Income Countries
    • Suzanne Elizabeth Edwards (Access to Medicine Foundation, Netherlands), Afshin Mehrpouya (MSCI Group - ESG Research), Frans Westerbos (Access to Medicine Foundation, Netherlands)
  • CEMA-Community to Improve Knowledge and Skills in Evaluating Medicine Advertisements
    • Chairun Wiedyaningsih (Gadjah Mada University, Indonesia), Nunung Priyatni (Gadjah Mada Unviersity, Indonesia), Siti Munawaroh (Agency for Women and Community Empowerment, Indonesia), Sri Suryawati (Gadjah Mada Unviersity, Indonesia)
  • “Under the Radar”: Nurse Prescribers and Pharmaceutical Industry Promotions
    • Elissa Ladd (MGH Institute of Health Professions, USA), Diane Mahoney (MGH Institute of Health Professions, USA), Emani Srinivas (Brigham and Womens Hospital)

Session 4b Video

 

 

Plenary 5: Consumers, Patients and Community Systems
Thursday, November 17, 2011
Presentations:

  • Can Markets Work to Scale Up Rational Drug Use?
    • Anthony D. So (Duke University, USA)
  • Scaling Up Community Management of Malaria - Challenges and Successes in EMRO Countries
    • Hoda Atta (WHO/EMRO, Egypt)
  • Access/Rational Use to TB Treatment Issues and Interventions
    • Samiha Baghdadi (EMRO/WHO, Egypt), Khaled Khalil (EMRO/WHO, Egypt)
  • Expanding Regulated Private Sector Medicines Access - Experiences with Accredited Drug Dispensing Outlets
    • Romuald Mbasi (Apotheker Consultancy Ltd)
  • Medicines Need and Access: Are there Gender Inequities?
    • Anita Katharina Wagner (Harvard Medical School, USA)

Plenary 5 Video

 

 

Session 5b: Policy: Consumers and Good Governance for Medicines
Thursday, November 17, 2011
Presentations:

  • Transparency Monitoring Study: A Rapid Assessment of Transparency in Key Functions of Pharmaceutical Services in 15 Countries
    • Rasha Saadi Hamra (WHO/Alliance for Healthy Policy and Systems Research, Lebanon), Alessandra Ferrario, Maryam Bigdeli, Guitelle Baghdadi-Sabeti
  • Corruption and High Medicine Prices in Vietnam: A Qualitative Study
    • Tuan Anh Nguyen (University of New South Wales, Australia; Hanoi University of Pharmacy, Vietnam), Rosemary Knight (University of New South Wales, Australia), Andrea Mant (University of New South Wales, Australia), Minh Quang Cao (MoH, Vietnam), Husna Razee (University of New South Wales, Australia)
  • Active Enforcement to Code of Conduct and Conflict of Interest Policies Based on Transparency Assessment Study in Jordan
    • Sana Naffa (WHO, Jordan), Adi Nseirat
  • Tsunami Drug Donations in Sri Lanka: Have the WHO Guidelines on Drug Donations been Effective in Meeting Public Health Pharmaceutical Needs in Times of Disaster?
    • Rohini Fernandopulle (University of Colombo, Sri Lanka), Hemantha Beneragama (MoH, Sri Lanka), Priyadarshini Gallappatthy (University of Colombo, Sri Lanka), Nilesh Fernandopulle (MoH, Sri Lanka)

Session 5b Video

 

 

Plenary 6: Strategies and Methods
Thursday, November 17, 2011
Presentations:

  • Key Strategies for Improving Use of Existing and New Antibiotics - the European Experience
    • Otto Gunnar Cars (ReAct/Uppsla University, Sweden)
  • Key Strategies for Developing and Facilitating Appropriate Use of New Antibiotics - Toward a New Business Model
    • Richard Bergstrom (EFPIA, Sweden), Brendan Barnes (EFPIA, Sweden)
  • Strengths and Challenges of Data for Medicines Use Research: Electronic Hospital Prescribing Data
    • Inthira Kanchanaphibool (Silpakorn University, Thailand)
  • Strengths and Challenges of Data for Medicines Use Research: Pharmaceutical Sales Data in Brazil
    • Andréa Homsi Dâmaso (Universidade Federal de Pelotas, Brazil)
  • Strengths and Challenges of Data for Medicines Use Research: Self-reported Medicines Information in Household Survey Data
    • Brian Serumaga (University of Nottingham, United Kingdom)

Plenary 6 Video

 
Highlights
 
Conference Proceedings
 
 
Agenda & Materials

Conference agenda and materials can be accessed here.